Retatrutide 15mg The 15mg vial format of retatrutide, Eli Lilly's triple GLP-1/GIP/glucagon receptor agonist a mid-to-high concentration option for metabolic research protocols spanning the upper end of the clinical dose-escalation range.
Multi-System Research Utility: Useful in metabolic, endocrine, and energy-regulation laboratory models
Explore full compound insights: Related Research Resources Disclaimer The statements made regarding this product have not been evaluated by regulatory authorities
Retatrutide is more accurately described as a triple receptor agonist research compound involving GLP-1, GIP, and glucagon receptor pathways
The following peptides are more effective for building muscle: Ipamorelin CJC-1295 GHRP-6 IGF-1 LR3 Follistatin Are There Any Interactions Between Retatrutide and Other Medications or Health Conditions
It is studied for interaction with GLP-1, GIP, and glucagon receptor pathways